The Latest Psychedelics Articles from Streetwise Reports

Opportunity for Investors Found in Psychedelics Space

Research Report

Patrick R. Trucchio (09/27/2022)

Treatment of alcohol use disorder with psychedelics plus therapy is effective, according to existing data, and the potential global market is large, noted an H.C. Wainwright & Co. report.

Tags: Psychedelics

Biotech Co.'s Target Six Times Current Price

Research Report

Francois Brisebois (09/13/2022)

One Phase 2 clinical trial showing LSD reduced symptoms of anxiety bodes well for other studies of LSD in this indication. In light of this, Oppenheimer & Co. gave this biotech company a target price that is over six times its current share price.

Tags: Psychedelics

Healthcare Co.'s To Develop Fast-Dissolving MDMA Tablet

Streetwise Reports (09/12/2022)

One biopharma co. is teaming with a much larger pharmaceutical company to develop a fast-dissolving oral tablet to deliver MDMA to patients with Alcohol Use Disorder. Find out why developing an oral tablet could benefit the company in the long run.

Tags: PsychedelicsBiotechnology / Pharmaceuticals

Expert Says Life Science Corp.'s Technical Case Is Becoming Compelling

Contributed Opinion

Clive Maund (09/07/2022)

Expert Clive Maund shares his view on Awakn Life Sciences Corp. as its stock continues to strengthen.

Tags: PsychedelicsBiotechnology / Pharmaceuticals

Healthcare Co. Wants Share of $17.5B Addiction Treatment Industry

Research Report

Jason McCarthy (07/14/2022)

One healthcare co. is currently rated a Buy and is making a push for a share of the $17.5-billion addiction treatment industry after a recent study showed its psychedelic-assisted psychotherapy treatment showed a significant decrease in alcohol use, noted a Maxim Group equity research report.

Tags: PsychedelicsHealthcare Services

Analyst Sees 'Attractive Long-Term Economics' for Healthcare Co.

Research Report

Andrew Partheniou (07/13/2022)

One healthcare company with upcoming catalysts wants to take a share of the CA$6-billion alcoholism treatment market with its proprietary psychedelic-assisted psychotherapy treatments.

Tags: PsychedelicsHealthcare Services

Drug Co. to Conduct P1/2a Trial of Psilocybin in Depression

Research Report

(06/27/2022)

In this trial, slated to commence next quarter, the biopharma will test the efficacy of its version of the psychedelic compound in this mental health indication, noted a ROTH Capital Partners report.

Tags: Psychedelics

Showing Results: 1 to 7 of 7